KW-3902IV

DRUG2 trials

Sponsors

NovaCardia, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)

Conditions

Heart Failure, CongestiveRenal Insufficiency

Phase 2

Dose Escalation Study of KW-3902 on Diuresis in Subjects With Congestive Heart Failure (CHF).

CompletedNCT00159627

NovaCardia, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)Heart Failure, Congestive

Start: 2004-08-31Target: 52Updated: 2008-01-29

Effect of KW-3902IV in Combination With IV Furosemide on Renal Function in Subjects With CHF and Renal Impairment

CompletedNCT00159614

NovaCardia, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)Heart Failure, Congestive, Renal Insufficiency

Start: 2005-09-30Target: 30Updated: 2008-01-29